Correlation Between Xenetic Biosciences and XTL Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xenetic Biosciences and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xenetic Biosciences and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xenetic Biosciences and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on Xenetic Biosciences and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xenetic Biosciences with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xenetic Biosciences and XTL Biopharmaceutica.

Diversification Opportunities for Xenetic Biosciences and XTL Biopharmaceutica

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Xenetic and XTL is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Xenetic Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xenetic Biosciences are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Xenetic Biosciences i.e., Xenetic Biosciences and XTL Biopharmaceutica go up and down completely randomly.

Pair Corralation between Xenetic Biosciences and XTL Biopharmaceutica

Given the investment horizon of 90 days Xenetic Biosciences is expected to generate 0.54 times more return on investment than XTL Biopharmaceutica. However, Xenetic Biosciences is 1.84 times less risky than XTL Biopharmaceutica. It trades about 0.07 of its potential returns per unit of risk. XTL Biopharmaceuticals Ltd is currently generating about 0.0 per unit of risk. If you would invest  377.00  in Xenetic Biosciences on October 21, 2024 and sell it today you would earn a total of  47.00  from holding Xenetic Biosciences or generate 12.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Xenetic Biosciences  vs.  XTL Biopharmaceuticals Ltd

 Performance 
       Timeline  
Xenetic Biosciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Xenetic Biosciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Xenetic Biosciences displayed solid returns over the last few months and may actually be approaching a breakup point.
XTL Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XTL Biopharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, XTL Biopharmaceutica is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Xenetic Biosciences and XTL Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xenetic Biosciences and XTL Biopharmaceutica

The main advantage of trading using opposite Xenetic Biosciences and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xenetic Biosciences position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.
The idea behind Xenetic Biosciences and XTL Biopharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance